{"id":"NCT01392677","sponsor":"AstraZeneca","briefTitle":"Evaluation of Safety and Efficacy of Dapagliflozin in Subjects With Type 2 Diabetes Who Have Inadequate Glycaemic Control on Background Combination of Metformin and Sulfonylurea","officialTitle":"A 24-week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, International Phase III Study With a 28-week Extension Period to Evaluate the Safety and Efficacy of Dapagliflozin 10mg Once Daily in Patients With Type 2 Diabetes Who Have Inadequate Glycaemic Control on a Background Combination of Metformin and Sulfonylurea","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-10","primaryCompletion":"2013-01","completion":"2013-08","firstPosted":"2011-07-12","resultsPosted":"2013-12-27","lastUpdate":"2014-03-12"},"enrollment":311,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus","High HbA1c Level","Inadequate Glycaemic Control"],"interventions":[{"type":"DRUG","name":"dapagliflozin","otherNames":[]},{"type":"DRUG","name":"placebo","otherNames":[]}],"arms":[{"label":"Dapagliflozin 10 mg tablet","type":"EXPERIMENTAL"},{"label":"matching placebo tablet","type":"PLACEBO_COMPARATOR"}],"summary":"This study intends to compare the efficacy and safety of dapagliflozin versus placebo in patients with type 2 diabetes who have inadequate glycaemic control on a background combination of metformin and sulfonylurea.","primaryOutcome":{"measure":"Adjusted Mean Change From Baseline in HbA1c Levels","timeFrame":"Baseline to week 24","effectByArm":[{"arm":"Placebo Plus Metformin Plus Sulfonylurea","deltaMin":-0.17,"sd":null},{"arm":"Dapagliflozin 10mg Plus Metformin Plus Sulfonylurea","deltaMin":-0.86,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":4},"locations":{"siteCount":42,"countries":["Canada","Czechia","Germany","Poland","Slovakia","Spain"]},"refs":{"pmids":["25592197"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_6111&studyid=1200&filename=D1693C00005.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":109},"commonTop":["urinary tract infection"]}}